Complex care
Coordinate first
May delay
Women’s Health Clinic FAQ
What is the safety profile of performing an O-Shot in postmenopausal women with advanced, treated genitourinary tuberculosis history?
Dialysis, alcohol dependence and previous genitourinary tuberculosis make O-Shot suitability a complex medical-history question.
Direct answer
A history of advanced treated genitourinary tuberculosis in a postmenopausal patient is a specialist-history question. The answer should prioritise records, current symptoms, tissue assessment and infection or urinary review before elective PRP.
The useful answer explains why complex medical history can change suitability, while avoiding protocols, medicine-stopping advice or promises of response.
Educational only. Use this as general education before discussing your own medical history with a clinician. Results vary. Not a cure.
O-Shot suitability review
At a glance
These points frame the medical-history question before considering elective intimate PRP.
At a glance
Clinical summary
Coordination
Dialysis timing, medicines, infection risk and bleeding risk may need medical coordination.
Systemic health
Alcohol dependence can affect liver health, nutrition, platelets, consent and healing context.
History matters
Treated genitourinary TB history may still require records and symptom review.
Elective procedure
Intimate PRP should be delayed if systemic illness, infection or unstable health is present.
Important safety note
Seek medical advice promptly for heavy or persistent bleeding, fever, offensive discharge, ulcers, severe pelvic or vulval pain, urinary retention, fainting, worsening swelling, suspected infection, systemic illness or unexplained genital lesions.
Alcohol
TB history
Coordination
Delay
Detailed answer
Detailed answer
Complex systemic histories can affect whether an elective intimate PRP procedure is appropriate, even when the local symptom feels separate.
Clinical context
Dialysis, alcohol dependence and previous genitourinary TB can raise questions about infection risk, bleeding, medicines, records and timing.
Tissue
Safety
Evidence
What matters first
Complex systemic histories can affect whether an elective intimate PRP procedure is appropriate, even when the local symptom feels separate.
Why review matters
Dialysis, alcohol dependence and previous genitourinary TB can raise questions about infection risk, bleeding, medicines, records and timing.
Evidence boundary
The public page should not publish scheduling modifications or medical protocols.
Safety boundary
The safer answer explains the need for coordination, stability and specialist context before deciding about treatment.
What this means in practice
A useful answer explains the clinical reason for caution without publishing protocols or implying suitability.
Medical history, medicines, tissue state and specialist input should be reviewed before elective intimate PRP.
Patient safety
Why this matters
Complex medical history can change blood draw safety, tissue resilience, infection risk, bleeding risk, pain interpretation and realistic expectations.
It avoids false reassurance
Autologous PRP does not automatically make treatment suitable for every complex history.
It protects sensitive tissue
Vulval, vaginal, neovaginal and periurethral tissue may be fragile, painful, scarred or affected by systemic illness.
It supports shared decisions
Some patients need oncology, renal, haematology, rheumatology, pelvic-floor or gender-surgery-aware input.
It keeps evidence honest
Intimate PRP protocols and patient groups vary, so outcomes should not be promised.
A careful treatment conversation
The question is not only whether PRP is biologically plausible, but whether it fits the patient's medical context.
That is why assessment, consent and follow-up are central to responsible intimate PRP care.
Considerations
What to consider
Consider the symptom target, diagnosis, medicines, bleeding history, infection risk, urinary symptoms, tissue fragility, surgery history, specialist follow-up and treatment goals.
Consultation priorities
The consultation reviews renal or liver history, dialysis schedule, medicines, infection history, TB records, urinary symptoms, bleeding and general health.
Medicines
Specialist
Follow-up
Assessment
The consultation reviews renal or liver history, dialysis schedule, medicines, infection history, TB records, urinary symptoms, bleeding and general health.
Safety review
The clinician considers whether GP, renal, infectious-disease, gynaecology or addiction-support input is needed first.
Treatment fit
If PRP remains a possibility, timing and aftercare should be individualised and documented through consent.
Review
Follow-up checks fever, discharge, urinary symptoms, bleeding, faintness, swelling or worsening pain.
Practical expectations
Response can be partial, delayed or absent, and published intimate PRP protocols are not uniform.
Prices, exact procedural details, treatment timing and aftercare should be confirmed with the clinic before booking.
Common concerns and myths
Common misconceptions
These myths can make complex suitability questions sound simpler than they are.
Myth: dialysis timing is just an admin issue
Reality: bleeding, infection risk, access and medicines may all matter.
Myth: alcohol dependence only affects paperwork
Reality: it can affect nutrition, platelets, healing and consent context.
Myth: treated TB is always irrelevant
Reality: previous genitourinary TB may still need records and symptom review.
Evidence and context
Mechanism helps explain why PRP is considered, but it does not replace diagnosis, specialist review or suitability checks.
Different outcomes
Comfort, arousal, lubrication, orgasm, urinary symptoms and pain are different outcomes and should not be blurred together.
Safety checklist
Safety checklist
Use these checks before assuming intimate PRP is suitable.
Is the medical history clear?
Clarify diagnosis, current stability, medicines, specialist follow-up and previous procedure reactions.
Has tissue context been reviewed?
Scarring, menopause-related change, infection symptoms, urinary issues, pain and active lesions can affect suitability.
Are red flags absent?
Pause and seek clinical review for new bleeding, fever, offensive discharge, ulcers, severe pain, urinary retention, fainting, spreading swelling, systemic illness or any concern about infection.
Is uncertainty documented?
Consent should explain limited evidence, variable response and possible discomfort, bruising or bleeding.
Reassuring signs
Proceeding is more reasonable when the condition is stable, red flags are absent and expectations are realistic.
No red flags
Review plan
Reasons to pause
Pause for unstable illness, new bleeding, infection symptoms, ulcers, severe pain, urinary retention, fainting, spreading swelling or uncertainty about medicine safety.
Infection
Unstable illness
When to escalate
When to seek medical help
Some symptoms around intimate PRP treatment need prompt assessment.
Use NHS 111 online
Bleeding or fainting
Heavy bleeding, persistent bleeding, spreading bruising or fainting should be assessed by a clinician.
Infection symptoms
Fever, offensive discharge, worsening burning, ulcers or pelvic pain may need swabs, urine testing or review.
Unexpected reaction
Worsening swelling, severe soreness, tissue colour change or new urinary difficulty should be reviewed.
Emergency symptoms
Call 999 in a life-threatening emergency, including collapse, chest pain, breathing difficulty or sudden neurological symptoms.
Use NHS 111 for urgent advice or call 999 in a life-threatening emergency. This page is educational and does not replace individual medical assessment.
More clinical detail
Why coordination matters
Elective intimate PRP should fit around the patient's wider medical safety, not the other way round.Why records can be important
For dialysis or previous genitourinary TB, treatment history, current symptoms and specialist advice may change whether PRP is sensible.Regulatory resources
Authoritative resources
These resources support evidence-aware, assessment-led discussion of intimate PRP and complex medical history.
O-Shot official questions
Competitor baseline for procedural simplicity claims that need complex-care caution.
PRP injections for female sexual dysfunction and SUI systematic review
Clinical literature anchor for intimate PRP uncertainty.
NHS dialysis
UK patient anchor for haemodialysis, scheduling and infection or bleeding considerations.
Next step
Book an intimate health consultation
A consultation can clarify whether symptoms fit GSM, sexual-function concerns, pelvic-floor pain, urinary symptoms or another cause, and whether PRP is suitable.
▶ View Research Sources (12 Sources)
These 12 source names are selected from 142 curated sources. Additional reviewed material included peer-reviewed clinical papers, evidence reviews, clinical trial records; duplicate and low-relevance records were removed before display.
Educational only. This information is for education only and is not a substitute for professional medical advice, diagnosis or treatment. Results vary. Not a cure.
